# Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers

> **NCT03420469** · EARLY_PHASE1 · COMPLETED · sponsor: **Indiana University** · enrollment: 28 (actual)

## Conditions studied

- Adverse Effect of Drug Therapy Metabolism Medications (Diagnosis)

## Interventions

- **DRUG:** Bupropion

## Key facts

- **NCT ID:** NCT03420469
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-05
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-05-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420469, "Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03420469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*